Samantha Digruccio

Endocrinology in Saint Louis, Missouri

Practice Details

Address
4921 Parkview Pl
Saint Louis, MO 63110
Geocoded location: 38.6382, -90.2632
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
MD
NPPES Enumeration
Listed with NPPES since 2017
Sole Proprietor
No
Provider Gender (NPPES)
Female
Also Listed As
Samantha Adamson
NPPES Record Updated
April 2025

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 98 Endocrinology, Diabetes & Metabolism practices in Saint Louis carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Samantha Digruccio's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 314-362-3500.

GLP-1 access in Saint Louis, Missouri

Adult obesity rate
35%
#13 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Missouri telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Missouri Medicaid, obesity indication

About 35% of Missouri adults have obesity (BMI 30+), ranking the state #13 of 50 (CDC BRFSS). Our directory currently lists 159 GLP-1-relevant clinics in Saint Louis. If a cash-pay route makes more sense, compounded semaglutide through Missouri telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Missouri options on the best Missouri GLP-1 providers page, browse every Saint Louis listing in the Saint Louis clinic directory, or read the Missouri Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Saint Louis

Other Saint Louis listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Missouri addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Missouri telehealth partners:

Featured Partners · Saint Louis

Featured GLP-1 providers serving Saint Louis

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  2. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →

See more Saint Louis options on the Saint Louis clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Saint Louis obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Samantha Digruccio's specialty taxonomy but not the specific medications it prescribes or its current service menu. Samantha Digruccio is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 314-362-3500 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Samantha Digruccio's primary specialty on file is Endocrinology.
Samantha Digruccio is located at 4921 Parkview Pl, Saint Louis, MO 63110. The phone number listed in the registry is 314-362-3500. Its full record is public in the CMS National Provider registry under NPI 1053831107.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Samantha Digruccio is currently accepting new patients. Call the practice at 314-362-3500 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.